Most cited papers from Paracelsus-Kliniken

Paracelsus-Kliniken

What are the most cited papers from Paracelsus-Kliniken?

The most cited paper from Paracelsus-Kliniken is "Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline" (Andrew J. Ullmann et al., 2018), with 1,576 citations. Next come "Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study" (403) and "Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net" (360).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 59 papers. Every paper with more than 50 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline Andrew J. Ullmann et al. · Clinical Microbiology and Infection Open access	18 Mar 2018	1,576
2	Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study Martin J. van den Bent et al. · The Lancet Open access	8 Aug 2017	403
3	Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net Michael Girschikofsky, Maurizio Aricò, Diego Castillo et al. · Orphanet Journal of Rare Diseases Open access	2013	360
4	Revised histopathological consensus classification of joint implant related pathology Veit Krenn et al. · Pathology - Research and Practice	16 Oct 2014	310
5	Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (α-lipoic acid): A two year multicenter randomized double-blind placebo-controlled trial (ALADIN II) M. Reljanović, G Reichel, Kristian RETT et al. · Free Radical Research	1999	284
6	Effects of Treatment With the Antioxidant α-Lipoic Acid on Cardiac Autonomic Neuropathy in NIDDM Patients: A 4-month randomized controlled multicenter trial (DEKAN Study) Dan Ziegler, Helmut Schatz, Frank Conrad et al. · Diabetes Care	Mar 1997	281
7	Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis Barbara Schormair et al. · The Lancet Neurology ReviewOpen access	13 Oct 2017	247
8	Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO) Sibylle C. Mellinghoff et al. · Annals of Hematology Open access	7 Dec 2017	218
9	A Double-Blind Randomised Placebo-Controlled Evaluation of Three Doses of Botulinum Toxin Type A (Dysport®) in the Treatment of Spastic Equinovarus Deformity after Stroke Sean Joseph Pittock, A. P. Moore, Orla M. Hardiman et al. · Cerebrovascular Diseases	2003	207
10	Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042) Damien Charles Weber, Carmen Ares, S. Villà et al. · Radiotherapy and Oncology Open access	28 Jun 2018	182
11	S2k-Leitlinie: Nichtinvasive und invasive Beatmung als Therapie der chronischen respiratorischen Insuffizienz – Revision 2017 W. Windisch et al. · Pneumologie	Nov 2017	180
12	Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport®) for the relief of upper back myofascial pain syndrome: Results from a randomized double-blind placebo-controlled multicentre study Hartmut Göbel, Axel Heinze, Gerhard Reichel et al. · Pain	6 Jun 2006	179
13	Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) Werner Heinz, Dieter Buchheidt, Maximilian Christopeit et al. · Annals of Hematology Open access	30 Aug 2017	177
14	Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide Gregor Paul Dresemann et al. · Journal of Neuro-Oncology Open access	17 Aug 2009	159
15	Current Practice of Temporary Vena Cava Filter Insertion: A Multicenter Registry Heike Lorch et al. · Journal of Vascular and Interventional Radiology	2000	158
16	Intraoperative magnetic resonance imaging to update interactive navigation in neurosurgery: Method and preliminary experience Christian Rainer Wirtz, Mario M. Bonsanto, Michael Knauth et al. · Computer Aided Surgery	1997	155
17	Advances in the diagnosis and treatment of fungal infections of the CNS Stefan Schwartz, Dimitrios P. Kontoyiannis, Thomas Stephen Harrison et al. · The Lancet Neurology	21 Feb 2018	141
18	Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma Martin H. Kropff, Nicola Lang, Guido Bisping et al. · British Journal of Haematology	Aug 2003	137
19	A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study Stefan Früehauf, Marlon Romano Veldwijk, Timon Seeger et al. · Cytotherapy	2009	123
20	Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial Jobst Christian von Einem, Volker Heinemann, Ludwig Fischer von Weikersthal et al. · Journal of Cancer Research and Clinical Oncology Open access	9 May 2014	114
21	Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy Wolfgang H. Jost, Harald Hefter, Andrea Stenner et al. · Journal of Neural Transmission Open access	16 Aug 2012	112
22	History and Possible Uses of Nanomedicine Based on Nanoparticles and Nanotechnological Progress Krukemeyer MG, Veit Krenn, F Huebner · Journal of Nanomedicine & Nanotechnology Open access	2015	111
23	A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy Maxi Wass et al. · Leukemia Open access	19 Jun 2020	102
24	Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria Markus Ruhnke, Renate Arnold, Petra Gastmeier · The Lancet Oncology Open access	23 Nov 2014	101
25	High-risk additional chromosomal abnormalities at low blast counts herald death by CML Rüdiger Hehlmann et al. · Leukemia Open access254 authors	7 May 2020	93
26	The updated ESTRO core curricula 2011 for clinicians, medical physicists and RTTs in radiotherapy/radiation oncology Jesper Grau Eriksen et al. · Radiotherapy and Oncology Open access	22 Mar 2012	93
27	Central and peripheral nervous system excitability in restless legs syndrome Giuseppe Lanza, Cornelius G. Bachmann, Imad Ghorayeb et al. · Sleep Medicine	2 Sep 2016	92
28	Effects of Transcutaneous Spinal Direct Current Stimulation in Idiopathic Restless Legs Patients Anne-Catherine Heide, Tobias Winkler, Hans‐Joachim Helms et al. · Brain stimulation Open access	2 Jul 2014	90
29	The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033 Pierre Bady et al. · Acta Neuropathologica Open access	24 Jan 2018	89
30	BRAF‐KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults Martin Hasselblatt, Barbara Riesmeier, Birgit Lechtape et al. · Neuropathology and Applied Neurobiology	23 Jun 2011	88
31	Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology ( AGIHO ) Markus Ruhnke et al. · Mycoses	11 Aug 2018	86
32	CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)—Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) Martin Schmidt‐Hieber, Gerda Silling, Enrico Schalk et al. · Annals of Oncology Open access	7 Apr 2016	82
33	Results of Prophylactic Irradiation in Patients with Resected Keloids: A retrospective analysis Martin Alfrink Wolfgang Wagner · Acta Oncologica Open access	2000	81
34	SPECT study of a German CADASIL family Jörg K. Mellies, Tobias Bäumer, Jochen A. Müller et al. · Neurology	Jun 1998	77
35	Nonsulfide Zinc Mineralization in Europe: An Overview Maria Boni, Duncan Large · Economic Geology	Jun 2003	74
36	Cervical dystonia: A new phenomenological classification for botulinum toxin therapy G Reichel · Basal Ganglia	17 Feb 2011	69
37	Cement Directed Kyphoplasty Reduces Cement Leakage as Compared With Vertebroplasty Thomas Joseph Vogl, Robert Pflugmacher, Johannes Hierholzer et al. · Spine	26 Jun 2013	69
38	Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients Stefan Früehauf, Gerhard Ehninger, Kai Hübel et al. · Bone Marrow Transplantation	13 Jul 2009	69
39	Cellular and reticular variants of haemangioblastoma revisited: a clinicopathologic study of 88 cases Martin Hasselblatt, Astrid Jeibmann, Joachim Gerß et al. · Neuropathology and Applied Neurobiology	8 Jul 2005	69
40	Targeted Resequencing and Systematic In Vivo Functional Testing Identifies Rare Variants in MEIS1 as Significant Contributors to Restless Legs Syndrome Eva Christina Schulte et al. · The American Journal of Human Genetics Open access	Jul 2014	67
41	Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+cell to Imatinib and Nilotinib Falk Dillmann, Marlon Romano Veldwijk, Stephanie Laufs et al. · Leukemia & lymphoma/Leukemia and lymphoma	2009	65
42	6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) is up-regulated in high-grade astrocytomas Renate Keßler, Franziska Bleichert, Jan‐Peter Warnke et al. · Journal of Neuro-Oncology	5 Sep 2007	64
43	Straining of the intact and fractured proximal humerus under physiological-like loading Zully M. Maldonado, Jörn Seebeck, Markus O.W. Heller et al. · Journal of Biomechanics	30 Jun 2003	64
44	15 years of the histopathological synovitis score, further development and review: A diagnostic score for rheumatology and orthopaedics Veit Krenn et al. · Pathology - Research and Practice	20 May 2017	62
45	Analysis of the Evolutionary Forces in an Immunodominant CD8 Epitope in Hepatitis C Virus at a Population Level Christoph Neumann‐Haefelin, David N. Frick, Jing Jing Wang et al. · Journal of Virology Open access	24 Jan 2008	62
46	Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group Brian Michael Alexander, Paul David Brown, Manmeet Singh Ahluwalia et al. · The Lancet Oncology Open access	29 Dec 2017	59
47	Erweiterte Konsensusklassifikation Veit Krenn, Lars Morawietz, H. Kienapfel et al. · Zeitschrift für Rheumatologie	27 Feb 2013	58
48	Zur Phänomenologie der zervikalen Dystonien G Reichel, Andrea Stenner, Anke Jahn · Fortschritte der Neurologie · Psychiatrie	May 2009	57
49	Human CYP4Z1 catalyzes the in-chain hydroxylation of lauric acid and myristic acid Andy Zöllner, Călin-Aurel Drăgan, Dominik Pistorius et al. · Biological Chemistry	17 Dec 2008	56
50	Signet Ring Cell Carcinoma of the Stomach Is Significantly Associated with Poor Prognosis and Diffuse Gastric Cancer (Lauren’s): Single-Center Experience of 160 Cases Holger G. Hass, Ute Smith, Christina Jäger et al. · Onkologie	2011	56

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.